Slate Bio

About:

Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases.

Website: https://slatebio.com

Top Investors: Epidarex Capital, Virginia Venture Partners, UVA Licensing & Ventures Group, PharmaDirections, VTC Seed Fund

Description:

Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.

Total Funding Amount:

$4.53M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Charlottesville, Virginia, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)slatebio.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-01-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai